Lam Research Co. (NASDAQ:LRCX) has been given an average rating of “Buy” by the twenty-seven ratings firms that are presently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $223.97.
Several equities research analysts recently issued reports on the stock. BidaskClub cut shares of Lam Research from a “hold” rating to a “sell” rating in a research report on Wednesday, August 15th. Evercore ISI cut their price objective on shares of Lam Research to $240.00 and set an “outperform” rating for the company in a research report on Tuesday, July 17th. Mizuho cut shares of Lam Research from a “buy” rating to a “neutral” rating in a research report on Monday, October 1st. Deutsche Bank restated a “hold” rating and set a $170.00 price objective (down from $230.00) on shares of Lam Research in a research report on Monday, October 1st. Finally, ValuEngine cut shares of Lam Research from a “hold” rating to a “sell” rating in a research report on Saturday, August 18th.
Hedge funds have recently made changes to their positions in the business. NuWave Investment Management LLC purchased a new position in Lam Research during the second quarter worth about $100,000. Clear Perspective Advisors LLC purchased a new position in Lam Research during the second quarter worth about $108,000. Signet Financial Management LLC boosted its stake in shares of Lam Research by 21,700.0% in the second quarter. Signet Financial Management LLC now owns 654 shares of the semiconductor company’s stock valued at $113,000 after purchasing an additional 651 shares during the period. Ruggie Capital Group purchased a new position in shares of Lam Research in the second quarter valued at approximately $134,000. Finally, Bollard Group LLC boosted its stake in shares of Lam Research by 43.0% in the second quarter. Bollard Group LLC now owns 1,005 shares of the semiconductor company’s stock valued at $174,000 after purchasing an additional 302 shares during the period. 89.79% of the stock is owned by institutional investors.
Shares of NASDAQ LRCX traded down $3.90 during mid-day trading on Monday, reaching $147.61. The company’s stock had a trading volume of 2,220,206 shares, compared to its average volume of 3,401,564. The stock has a market capitalization of $23.51 billion, a price-to-earnings ratio of 8.26, a price-to-earnings-growth ratio of 0.88 and a beta of 1.30. The company has a quick ratio of 2.00, a current ratio of 2.66 and a debt-to-equity ratio of 0.34. Lam Research has a 1-year low of $133.42 and a 1-year high of $234.88.
Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Tuesday, October 16th. The semiconductor company reported $3.36 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.22 by $0.14. Lam Research had a net margin of 21.26% and a return on equity of 49.80%. The firm had revenue of $2.33 billion during the quarter, compared to analysts’ expectations of $2.31 billion. During the same period last year, the business earned $3.46 earnings per share. Lam Research’s revenue was down 6.0% compared to the same quarter last year. As a group, equities research analysts expect that Lam Research will post 14.37 EPS for the current year.
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits worldwide. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition product for copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatment; SPEED gapfill high-density plasma chemical vapor deposition (CVD) products; Striker single-wafer atomic layer deposition (ALD) products; and VECTOR plasma-enhanced CVD ALD products.
Featured Article: Day Trading
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.